Skip to main content

Design and Construction of Microbial Cell Factories for the Production of Fuels and Chemicals

97kviews
Editorial19 April 2023
Editorial: Design and construction of microbial cell factories for the production of fuels and chemicals

Green biomanufacturing refers to the advanced production of biofuels, bio-based chemicals and products using industrial biotechnology (Chi et al., 2019;Straathof et al., 2019;Lv et al., 2020;Ye et al., 2023). Microbial cell factories are the central aspect of green biomanufacturing. By introducing heterologous biosynthetic pathways and then modulating complex metabolic flux intracellularly, various fuels and chemicals can be produced in an economically feasible manner (Gong et al., 2017;Li et al., 2018;Banner et al., 2021). Compared with chemical synthesis and plant extraction, microbial cell factories are not restricted by external factors such as geography, climate and expensive catalysts (Liu et al., 2021;Cho et al., 2022). At the same time, due to the inherent advantages including shorter production cycles and higher yield, using microbial cell factories for chemical production has been paid more attention. In this research topic, the design and construction of microbial cell factories for the production of fuels and chemicals were extensively discussed. Ma et al. developed a hybrid system that hired both synthetic biology-based methods (Sbio) and chemical synthesis based methods (Csyn) to synthesize clinically significant and structurally complex chanoclavine to overcome the limitations of Sbio and Csyn which could boost the production of complex natural products. The model organisms like Saccharomyces cerevisiae, Escherichia coli and Corynebacterium glutamicum have good potential as microbial cell factories due to their clear genetic background and powerful genetic manipulation tools (Yilmaz and Walhout, 2017). Wang et al. constructed a heterologous biosynthetic pathway in S. cerevisiae for mogrol production. The mogrol pathway was divided into three modules and the metabolic flux of these three modules was optimized. Finally, the mogrol titer was increased to 9.1 μg/L which was 455-fold higher than that of the original strain. Guo et al. used E. coli as a host cell to produce D-allulose from Dfructose via in vivo phosphorylation-dephosphorylation. After replacing the fructose phosphotransferase systems, blocking the carbon flux and introducing an ATP regeneration system, this engineered cell factory cultured in M9 medium with glycerol as a carbon source achieved a D-allulose titer of ≈ 1.59 g/L and a yield of ≈ 0.72 g/g on D-fructose. C. glutamicum is considered a promising strain for O-Acetylhomoserine (OAH) production. Li et al constructed an efficient clustered regularly interspaced short palindromic repeats/dead CRISPR-associated protein 9 (CRISPR-dCas9) system to identify the key genes in central metabolism and branch pathways associated with OAH biosynthesis. 25.9 g/L OAH was obtained by the engineered strain which provides a better research basis for the industrial production of OAH in C. glutamicum. Apart from model organisms, several non-model organisms have also been used as cell factories for the production of high-value chemicals due to their unique advantages (Nielsen, 2019). The industrial production of iturin and fengycin relies on bacterial fermentation rather than chemical synthesis but still suffer from low yields. Wang et al. developed a systematic engineering approach to improve the antifungal activity and biosynthesis of iturin and fengycin in Bacillus amyloliquefaciens including increasing precursor supply of the branched-chain amino acids, disrupting sporulation to extend the stage for producing antifungal lipopeptides, blocking siderophore synthesis to enhance the availability of amino acids and fatty acids, and increasing phosphorylated Spo0A by knocking out rap protein. After combined regulation and fermentation optimization, the titer of iturin and fengycin in the final engineered strain reached 31.1 mg/L and 175.3 mg/L in a flask, and 123.5 mg/L and 1200.8 mg/L in a bioreactor. Li et al evaluated Gluconobacter oxydans ATCC9937 for the production of 2,5-diketo-D-gluconic acid (2,5-DKG) and identified the non-enzymatic browning of 2,5-DKG. After optimizing the fermentation process, the titer of 2,5-DKG increased to 50.9 g/L which provided a basis for further increases in titer of 2,5-DKG. Yarrowia lipolytica is an excellent chassis cell due to its ability to utilize a wide range of substrates, accumulate lipids, and resist poor industrial fermentation environment (Larroude et al., 2018;Patra et al., 2021). Zhu et al and Liang et al achieved efficient production of lipids and erythritol using Y. lipolytica as the host, respectively. Their researches have contributed to a deeper understanding of the Y. lipolytica cell factory, laying the foundation for the production of other high-value chemicals. In summary, the selection of suitable host cells is a prerequisite for the efficient production of high-value compounds.The development of effective strategies is also essential to obtain a robust cell factory. A variety of strategies have driven the rapid development of synthetic biology which enabled us to efficiently edit the genome of host cells to achieve precise regulation and optimization of their genetic components, synthetic pathways, and metabolic networks, and ultimately to build cell factories for the efficient production of high-value compounds (Liu et al., 2022). Ma et al. developed a transposon-mediated random deletion method that allows the random and continuous reduction of E. coli genome. Using this strategy, a polyhydroxybutyrate overproduction strain has been obtained with better growth, glucose utilization, protein expression, and a significant increase in electroporation efficiency. Gambacorta et al. used a combinatorial library design and a growth-coupled screening to identify an isobutanol pathway cassette capable of supporting a higher carbon flux to select for both high isobutanol and high ethanol producing strain. Conversion of cheap feedstock to value-added chemicals via green biological processes may provide an attractive approach toward carbon neutrality (Zhu et al., 2020). Methanol is favored for its abundance, low price and highly reducible properties (Wang et al., 2020). Sun et al reprogrammed E. coli metabolism to improve methanol assimilation by combining rational design and adaptive laboratory evolution.Protein engineering is a promising approach to improving enzyme performance, including catalytic activity, stability, selectivity and tolerance (Yang et al., 2019;Yuan et al., 2022). Recently, Huang et al. employed a computer-aided protein design strategy to improve the catalytic efficiency and substrate specificity of the α-L-rhamnosidase from Thermotoga petrophila DSM 13995. The best mutant showed a catalytic efficiency increased 209-fold. With the increasing research on cell factories and the growing amount of experimental data, genome-scale metabolic models (GSMs) have been developed for network property analysis, cell phenotype prediction, metabolic engineering guidance, model-driven discovery, evolutionary process exploration, and interspecies interaction identification (Ye et al., 2022). Zhang et al. reconstructed the GEM of Streptomyces radiopugnans iZDZ767. The culture conditions were optimized and the potential geosmin overproduction targets were identified, the titer of geosmin reached to 581.6 ng/L. The model iZDZ767 is a powerful tool for analyzing and predicting the metabolic pathways and yields of various products in S. radiopugnans, which provides convenient conditions for researchers to study S. radiopugnans in the field of systems biology. In recent years, droplet-based microfluidics as an emerging high-throughput screening technology can generate uniformly sized, mutually independent droplets with remarkable features such as high speed, high throughput, and low cost for the screening of a variety of microorganisms, expanding the existing strain library and improving the product titer, which will pave the way for the construction of microbial cell factories (Leavell et al., 2020;Yuan et al., 2022). Zhang et al reviewed the recent applications of droplet-based microfluidics which provides a useful quickglance reference for anyone interested in high-throughput screening technology.The construction of efficient microbial cell factories for the production of highvalue compounds is an inevitable trend for sustainable industrial production. This research topic not only covers a rich diversity of microbial hosts and high-value chemicals but also introduces several promising metabolic engineering strategies. In general, numerous studies have been conducted to modify host cells to enhance product titers, including the expansion of strain libraries, optimization and regulation of biosynthetic pathways, improvement of enzyme properties, and refinement of gene editing tools. We firmly believe that the rapid development of biotechnology will pave the way for the construction of microbial cell factories in the green biomanufacturing industry.

3,694 views

10 citations

PERSPECTIVE
10 March 2023
High-throughput screening of microbial strains in large-scale microfluidic droplets
Zhidong Zhang, 2 more and He Huang
High-throughput screening of microbial strains in large-scale microfluidic droplets
The transformation of engineered microbial cells is one pivotal link in green biomanufacturing. Its representative application research involves genetic modification of microbial chassis to impart them targeted traits and functions able to more effectively synthesize the desired products. Microfluidics, as an emerging complementary solution, focuses on controlling and manipulating the fluid in the channels at the microscopic scale. One of its subcategories is droplet-based microfluidics (DMF), which could generate discrete droplets through immiscible multiphase fluids at kHz frequencies. Up to now, the droplet microfluidics has been successfully applied to a variety of microbes covering bacteria, yeast, and filamentous fungi, and realized the detection of massive metabolites of strain products, such as polypeptides, enzymes, and lipids. In summary, we firmly believe that droplet microfluidics has evolved into a powerful technology that will pave the way for high-throughput screening of engineered microbial strains in green biomanufacturing industry.

7,889 views

19 citations

ORIGINAL RESEARCH
17 February 2023
Construction and application of the genome-scale metabolic model of Streptomyces radiopugnans
Zhidong Zhang, 3 more and He Huang

4,132 views

7 citations

ORIGINAL RESEARCH
13 January 2023
Knocking out central metabolism genes to identify new targets and alternating substrates to improve lipid synthesis in Y. lipolytica
Jiang Zhu, 4 more and Peng Xu

5,092 views

11 citations

ORIGINAL RESEARCH
2 December 2022
Combinatorial library design for improving isobutanol production in Saccharomyces cerevisiae
Francesca V. Gambacorta, 4 more and Brian F. Pfleger

5,264 views

9 citations

ORIGINAL RESEARCH
21 December 2022
A hybrid system for the overproduction of complex ergot alkaloid chanoclavine
Yaqing Ma, 5 more and Chengsen Cui

3,512 views

4 citations

Systemically engineering Bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production
ORIGINAL RESEARCH
7 September 2022
Systemically engineering Bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production
Susheng Wang, 6 more and Gaofu Qi
The biosynthesis of antifungal lipopeptides iturin and fengycin has attracted broad interest; however, there is a bottleneck in its low yield in wild strains. Because the key metabolic mechanisms in the lipopeptides synthesis pathway remain unclear, genetic engineering approaches are all ending up with a single or a few gene modifications. The aim of this study is to develop a systematic engineering approach to improve the antifungal activity and biosynthesis of iturin and fengycin in Bacillus amyloliquefaciens. First, blocking the carbon overflow metabolic pathway to increase precursor supply of the branched-chain amino acids by knockout of bdh, disrupting sporulation to extend the stage for producing antifungal lipopeptides by deletion of kinA, blocking of siderophore synthesis to enhance the availability of amino acids and fatty acids by deletion of dhbF, and increasing Spo0A~P by deletion of rapA, could improve the antifungal activity by 24%, 10%, 13% and 18% respectively. Second, the double knockout strain ΔbdhΔkinA, triple knockout strain ΔbdhΔkinAΔdhbF and quadruple knockout strain ΔkinAΔbdhΔdhbFΔrapA could improve the antifungal activity by 38%, 44% and 53% respectively. Finally, overexpression of sfp in ΔkinAΔbdhΔdhbFΔrapA further increased the antifungal activity by 65%. After purifying iturin and fengycin as standards for quantitative analysis of lipopeptides, we found the iturin titer was 17.0 mg/L in the final engineered strain, which was 3.2-fold of the original strain. After fermentation optimization, the titer of iturin and fengycin reached 31.1 mg/L and 175.3 mg/L in flask, and 123.5 mg/L and 1200.8 mg/L in bioreactor. Compared to the original strain, the iturin and fengycin titer in bioreactor increased by 22.8-fold and 15.9-fold in the final engineered strain respectively. This study may pave the way for the commercial production of green antifungal lipopeptides, and is also favorable for understanding the regulatory and biosynthetic mechanism of iturin and fengycin.

7,900 views

33 citations

ORIGINAL RESEARCH
29 August 2022
Random genome reduction coupled with polyhydroxybutyrate biosynthesis to facilitate its accumulation in Escherichia coli
Shuai Ma, 5 more and Qingsheng Qi

3,362 views

7 citations

Metabolically Engineered Escherichia coli for Conversion of D-Fructose to D-Allulose via Phosphorylation-Dephosphorylation
ORIGINAL RESEARCH
22 June 2022
Metabolically Engineered Escherichia coli for Conversion of D-Fructose to D-Allulose via Phosphorylation-Dephosphorylation
Qiang Guo, 7 more and Xiao-Cheng Lin
D-Allulose is an ultra-low calorie sweetener with broad market prospects. As an alternative to Izumoring, phosphorylation-dephosphorylation is a promising method for D-allulose synthesis due to its high conversion of substrate, which has been preliminarily attempted in enzymatic systems. However, in vitro phosphorylation-dephosphorylation requires polyphosphate as a phosphate donor and cannot completely deplete the substrate, which may limit its application in industry. Here, we designed and constructed a metabolic pathway in Escherichia coli for producing D-allulose from D-fructose via in vivo phosphorylation-dephosphorylation. PtsG-F and Mak were used to replace the fructose PTS for uptake and phosphorylation of D-fructose to fructose-6-phosphate, which was then converted to D-allulose by AlsE and A6PP. The D-allulose titer reached 0.35 g/L and the yield was 0.16 g/g. Further block of the carbon flux into the Embden-Meyerhof-Parnas (EMP) pathway and introduction of an ATP regeneration system obviously improved fermentation performance, increasing the titer and yield of D-allulose to 1.23 g/L and 0.68 g/g, respectively. The E. coli cell factory cultured in M9 medium with glycerol as a carbon source achieved a D-allulose titer of ≈ 1.59 g/L and a yield of ≈ 0.72 g/g on D-fructose.

6,625 views

26 citations

Construction and Optimization of the de novo Biosynthesis Pathway of Mogrol in Saccharomyces Cerevisiae
Mogrol plays important roles in antihyperglycemic and antilipidemic through activating the AMP-activated protein kinase pathway. Although the synthesis pathway of mogrol in Siraitia grosvenorii has been clarified, few studies have focused on improving mogrol production. This study employed a modular engineerin g strategy to improve mogrol production in a yeast chassis cell. First, a de novo synthesis pathway of mogrol in Saccharomyces cerevisiae was constructed. Then, the metabolic flux of each synthetic module in mogrol metabolism was systematically optimized, including the enhancement of the precursor supply, inhibition of the sterol synthesis pathway using the Clustered Regularly Interspaced Short Palindromic Repeats Interference system (CRISPRi), and optimization of the expression and reduction system of P450 enzymes. Finally, the mogrol titer was increased to 9.1 μg/L, which was 455-fold higher than that of the original strain. The yeast strains engineered in this work can serve as the basis for creating an alternative way for mogrol production in place of extraction from S. grosvenorii.

7,194 views

26 citations

ORIGINAL RESEARCH
21 June 2022
Computer-Aided Design of α-L-Rhamnosidase to Increase the Synthesis Efficiency of Icariside I
Jia-Jun Huang, 4 more and Mingtao Huang

3,698 views

9 citations